
# Table of Contents

-   [Technical Skills](#org926dddd)
-   [Experience](#org5b10ec6)
    -   [META](#org59b82d4)
        -   [Research Engineer (IC6)](#org3443cae)
    -   [SCAPE TECHNOLOGIES](#org823dcc2)
        -   [Machine Learning Engineer](#orga97efcd)
    -   [DELOITTE CONSULTING LLP](#orgead72f6)
        -   [Senior Consultant](#orgcd4a1ad)
    -   [US FOOD AND DRUG ADMINISTRATION](#org5fd004b)
        -   [Quantitative Research Fellow](#org57024f3)
-   [Education](#orgd027e06)
    -   [University of Michigan](#org70abf73)
        -   [PhD Pharmaceutical Sciences](#orgb7da125)
    -   [New York University](#org85f6b91)
        -   [MSc Computational Biology](#orgbf94ae6)
    -   [University of Arizona](#orgbc45443)
        -   [BSc Mathematics](#org057c9cf)

Software engineer, building robust & scalable sytems. US Citizen and UK ILR.


<a id="org926dddd"></a>

# Technical Skills

-   Python, Rust, C++, SQL, Cloud infrastructure (AWS, GCP)


<a id="org5b10ec6"></a>

# Experience


<a id="org59b82d4"></a>

## META


<a id="org3443cae"></a>

### Research Engineer (IC6)

-   Developing the next generation of computation in Reality Labs Research, building the digital interface for the physical world
-   **Geospatial Ingestion and Indexing** &#x2013; *Python, C++*
    -   Creator and maintainer of the pipeline, enabling search and discovery of audio-video data from Project Aria (see <https://about.meta.com/uk/realitylabs/projectaria/>)
-   **Distributed Computing** &#x2013; *Python, C++*
    -   Enabled distributed computing to run large-scale optimization libraries on Meta cloud infrastructure
-   Contributed to upgrading company-wide libraries &#x2013; *Rust*
-   Promotion from IC5 to IC6 (July 2022) and 3 consecutive performance ratings of Exceeded Expectations


<a id="org823dcc2"></a>

## SCAPE TECHNOLOGIES


<a id="orga97efcd"></a>

### Machine Learning Engineer

-   Acquired by Facebook January 2020
-   Building core data flow and analysis pipeline for location-based recognition, allowing devices to see and remember
    their surroundings and augment the world around them. Cloud infrastructure allows ordinary mobile devices to enhance
    the world around them by overlaying digital items onto the physical world, both indoors and outdoors, using machine vision
    and artificial intelligence.
-   **Large-Scale Structure-from-Motion Pipeline** &#x2013; *Python, C++, PyTorch, AWS, PostgreSQL, Redis*
    -   Deploying and optimizing large computer vision end-to-end processing pipeline.
    -   Developing and optimizing code base to improve runtime and significantly reduce costs.
    -   Deep learning-based global image feature extraction and large-scale image retrieval.
    -   Custom cloud-based graph database deployment for geospatial image data used in pipeline to build 3D geometric models.


<a id="orgead72f6"></a>

## DELOITTE CONSULTING LLP


<a id="orgcd4a1ad"></a>

### Senior Consultant

-   Mission Analytics in Business Model and Transformation/Strategy and Operations.
-   Supporting senior government executives in the development of the organization&rsquo;s
    strategy and business process; assisting in development, collection, analysis,
    and reporting of data by leverage big data and machine learning technologies; serving as domain
    knowledgeable resource in advising the Deloitte team and client on tools and techniques to improve workflow.
-   **Distributed Graph Database Analytics** &#x2013; *Scala, Java, Kafka, Cassandra/NoSQL*
    -   Leveraging Cassandra and Spark for large-scale graph networks and analyses including:
        -   Migration of client data from on-prem to cloud (AWS)
        -   Building tools to explore and analyze graph data in a distributed system
        -   Developing machine learning algorithms and automation of real-time entity resolution (data disambiguation) at scale.
        -   Dealing with 10<sup>7</sup> (eventually reaching 10<sup>9</sup>) daily transactions utilizing Kafka and Spark Streaming to ingest massive amounts of data through an ETL pipeline.
        -   Revenue increase from $1.8M to $6.0M; internal investment by firm ($0.5M) to generalize new capability based on client deliverable (see <https://www2.deloitte.com/content/dam/Deloitte/de/Documents/operations/knowledge-graphs-pov.pdf>)


<a id="org5fd004b"></a>

## US FOOD AND DRUG ADMINISTRATION


<a id="org57024f3"></a>

### Quantitative Research Fellow

-   Division of Quantitative Methods and Modeling in the Office of Research and Standards within the Office of Generic Drugs.
-   Applying mathematical analysis to physiological/molecular based models for drug absorption, bioavailability, distribution
    and effectiveness. Using large data sets to improve the prediction and regulatory decision making for generic drugs.


<a id="orgd027e06"></a>

# Education


<a id="org70abf73"></a>

## University of Michigan


<a id="orgb7da125"></a>

### PhD Pharmaceutical Sciences

-   *Mechanistic Analysis and Quantification of Gastrointestinal Motility: Physiological Variability and Plasma Level Implications*


<a id="org85f6b91"></a>

## New York University


<a id="orgbf94ae6"></a>

### MSc Computational Biology


<a id="orgbc45443"></a>

## University of Arizona


<a id="org057c9cf"></a>

### BSc Mathematics

<div id="bibliography">
<h2>References</h2>

</div>
<table>

<tr valign="top">
<td align="right" class="bibtexnumber">
[<a name="Hens2017a">Hens et&nbsp;al.(2017a)Hens, Corsetti, Spiller, Marciani,
  Vanuytsel, Tack, Talattof, Amidon, Koziolek, Weitschies, Wilson, Bennink,
  Brouwers, and Augustijns</a>]
</td>
<td class="bibtexitem">
B.&nbsp;Hens, M.&nbsp;Corsetti, R.&nbsp;Spiller, L.&nbsp;Marciani, T.&nbsp;Vanuytsel, J.&nbsp;Tack,
  A.&nbsp;Talattof, G.&nbsp;L. Amidon, M.&nbsp;Koziolek, W.&nbsp;Weitschies, C.&nbsp;G. Wilson, R.&nbsp;J.
  Bennink, J.&nbsp;Brouwers, and P.&nbsp;Augustijns.
 Exploring gastrointestinal variables affecting drug and formulation
  behavior: Methodologies, challenges and opportunities.
 <em>International Journal of Pharmaceutics</em>, 5190
  (1-2):0 79--97, mar 2017a.
 ISSN 03785173.
 10.1016/j.ijpharm.2016.11.063.
 URL
  <a href="http://linkinghub.elsevier.com/retrieve/pii/S0378517316311267">http://linkinghub.elsevier.com/retrieve/pii/S0378517316311267</a>.
[&nbsp;<a href="refs_bib.html#Hens2017a">bib</a>&nbsp;| 
<a href="http://dx.doi.org/10.1016/j.ijpharm.2016.11.063">DOI</a>&nbsp;| 
<a href="http://linkinghub.elsevier.com/retrieve/pii/S0378517316311267">http</a>&nbsp;]

</td>
</tr>


<tr valign="top">
<td align="right" class="bibtexnumber">
[<a name="Hens2017">Hens et&nbsp;al.(2017b)Hens, Tsume, Bermejo, Paixao,
  Koenigsknecht, Baker, Hasler, Lionberger, Fan, Dickens, Shedden, Wen,
  Wysocki, Loebenberg, Lee, Frances, Amidon, Yu, Benninghoff, Salehi, Talattof,
  Sun, and Amidon</a>]
</td>
<td class="bibtexitem">
B.&nbsp;Hens, Y.&nbsp;Tsume, M.&nbsp;Bermejo, P.&nbsp;Paixao, M.&nbsp;J. Koenigsknecht, J.&nbsp;R. Baker,
  W.&nbsp;L. Hasler, R.&nbsp;Lionberger, J.&nbsp;Fan, J.&nbsp;Dickens, K.&nbsp;Shedden, B.&nbsp;Wen,
  J.&nbsp;Wysocki, R.&nbsp;Loebenberg, A.&nbsp;Lee, A.&nbsp;Frances, G.&nbsp;Amidon, A.&nbsp;Yu,
  G.&nbsp;Benninghoff, N.&nbsp;Salehi, A.&nbsp;Talattof, D.&nbsp;Sun, and G.&nbsp;L. Amidon.
 Low Buffer Capacity and Alternating Motility along the Human
  Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption
  of Ionizable Drugs.
 <em>Molecular Pharmaceutics</em>, 140 (12):0
  4281--4294, dec 2017b.
 ISSN 1543-8384.
 10.1021/acs.molpharmaceut.7b00426.
 URL <a href="http://pubs.acs.org/doi/10.1021/acs.molpharmaceut.7b00426">http://pubs.acs.org/doi/10.1021/acs.molpharmaceut.7b00426</a>.
[&nbsp;<a href="refs_bib.html#Hens2017">bib</a>&nbsp;| 
<a href="http://dx.doi.org/10.1021/acs.molpharmaceut.7b00426">DOI</a>&nbsp;| 
<a href="http://pubs.acs.org/doi/10.1021/acs.molpharmaceut.7b00426">http</a>&nbsp;]

</td>
</tr>


<tr valign="top">
<td align="right" class="bibtexnumber">
[<a name="Hens2018">Hens et&nbsp;al.(2018)Hens, Talattof, Paix&atilde;o, Bermejo, Tsume,
  L&ouml;benberg, and Amidon</a>]
</td>
<td class="bibtexitem">
B.&nbsp;Hens, A.&nbsp;Talattof, P.&nbsp;Paix&atilde;o, M.&nbsp;Bermejo, Y.&nbsp;Tsume,
  R.&nbsp;L&ouml;benberg, and G.&nbsp;L. Amidon.
 Measuring the Impact of Gastrointestinal Variables on the Systemic
  Outcome of Two Suspensions of Posaconazole by a PBPK Model.
 <em>The AAPS Journal</em>, 200 (3):0 57, may 2018.
 ISSN 1550-7416.
 10.1208/s12248-018-0217-6.
 URL <a href="http://link.springer.com/10.1208/s12248-018-0217-6">http://link.springer.com/10.1208/s12248-018-0217-6</a>.
[&nbsp;<a href="refs_bib.html#Hens2018">bib</a>&nbsp;| 
<a href="http://dx.doi.org/10.1208/s12248-018-0217-6">DOI</a>&nbsp;| 
<a href="http://link.springer.com/10.1208/s12248-018-0217-6">http</a>&nbsp;]

</td>
</tr>


<tr valign="top">
<td align="right" class="bibtexnumber">
[<a name="lacount2020modeling">LaCount et&nbsp;al.(2020)LaCount, Zhang, Hao, Ghosh, Raney, Talattof,
  Kasting, and Li</a>]
</td>
<td class="bibtexitem">
T.&nbsp;D. LaCount, Q.&nbsp;Zhang, J.&nbsp;Hao, P.&nbsp;Ghosh, S.&nbsp;G. Raney, A.&nbsp;Talattof, G.&nbsp;B.
  Kasting, and S.&nbsp;K. Li.
 Modeling temperature-dependent dermal absorption and clearance for
  transdermal and topical drug applications.
 <em>The AAPS journal</em>, 22:0 1--13, may 2020.
 10.1208/s12248-020-00451-2.
 URL <a href="https://doi.org/10.1208/s12248-020-00451-2">https://doi.org/10.1208/s12248-020-00451-2</a>.
[&nbsp;<a href="refs_bib.html#lacount2020modeling">bib</a>&nbsp;| 
<a href="http://dx.doi.org/10.1208/s12248-020-00451-2">DOI</a>&nbsp;| 
<a href="https://doi.org/10.1208/s12248-020-00451-2">http</a>&nbsp;]

</td>
</tr>


<tr valign="top">
<td align="right" class="bibtexnumber">
[<a name="Paixao2018">Paix&atilde;o et&nbsp;al.(2018)Paix&atilde;o, Bermejo, Hens, Tsume, Dickens,
  Shedden, Salehi, Koenigsknecht, Baker, Hasler, Lionberger, Fan, Wysocki, Wen,
  Lee, Frances, Amidon, Yu, Benninghoff, L&ouml;benberg, Talattof, Sun, and
  Amidon</a>]
</td>
<td class="bibtexitem">
P.&nbsp;Paix&atilde;o, M.&nbsp;Bermejo, B.&nbsp;Hens, Y.&nbsp;Tsume, J.&nbsp;Dickens, K.&nbsp;Shedden,
  N.&nbsp;Salehi, M.&nbsp;J. Koenigsknecht, J.&nbsp;R. Baker, W.&nbsp;L. Hasler, R.&nbsp;Lionberger,
  J.&nbsp;Fan, J.&nbsp;Wysocki, B.&nbsp;Wen, A.&nbsp;Lee, A.&nbsp;Frances, G.&nbsp;E. Amidon, A.&nbsp;Yu,
  G.&nbsp;Benninghoff, R.&nbsp;L&ouml;benberg, A.&nbsp;Talattof, D.&nbsp;Sun, and G.&nbsp;L. Amidon.
 Gastric emptying and intestinal appearance of nonabsorbable drugs
  phenol red and paromomycin in human subjects: A multi-compartment stomach
  approach.
 <em>European Journal of Pharmaceutics and Biopharmaceutics</em>,
  129:0 162--174, aug 2018.
 ISSN 09396411.
 10.1016/j.ejpb.2018.05.033.
 URL
  <a href="https://linkinghub.elsevier.com/retrieve/pii/S0939641118304041">https://linkinghub.elsevier.com/retrieve/pii/S0939641118304041</a>.
[&nbsp;<a href="refs_bib.html#Paixao2018">bib</a>&nbsp;| 
<a href="http://dx.doi.org/10.1016/j.ejpb.2018.05.033">DOI</a>&nbsp;| 
<a href="https://linkinghub.elsevier.com/retrieve/pii/S0939641118304041">http</a>&nbsp;]

</td>
</tr>


<tr valign="top">
<td align="right" class="bibtexnumber">
[<a name="Talattof2018">Talattof and Amidon(2018)</a>]
</td>
<td class="bibtexitem">
A.&nbsp;Talattof and G.&nbsp;L. Amidon.
 Pulse Packet Stochastic Model for Gastric Emptying in the Fasted
  State: A Physiological Approach.
 <em>Molecular Pharmaceutics</em>, 150 (6):0 2107--2115,
  jun 2018.
 ISSN 1543-8384.
 10.1021/acs.molpharmaceut.7b01077.
 URL <a href="http://pubs.acs.org/doi/10.1021/acs.molpharmaceut.7b01077">http://pubs.acs.org/doi/10.1021/acs.molpharmaceut.7b01077</a>.
[&nbsp;<a href="refs_bib.html#Talattof2018">bib</a>&nbsp;| 
<a href="http://dx.doi.org/10.1021/acs.molpharmaceut.7b01077">DOI</a>&nbsp;| 
<a href="http://pubs.acs.org/doi/10.1021/acs.molpharmaceut.7b01077">http</a>&nbsp;]

</td>
</tr>


<tr valign="top">
<td align="right" class="bibtexnumber">
[<a name="Talattof2016">Talattof et&nbsp;al.(2016)Talattof, Price, and Amidon</a>]
</td>
<td class="bibtexitem">
A.&nbsp;Talattof, J.&nbsp;C. Price, and G.&nbsp;L. Amidon.
 Gastrointestinal Motility Variation and Implications for Plasma
  Level Variation: Oral Drug Products.
 <em>Molecular Pharmaceutics</em>, 130 (2):0 557--567,
  feb 2016.
 ISSN 1543-8384.
 10.1021/acs.molpharmaceut.5b00774.
 URL <a href="http://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5b00774">http://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5b00774</a>.
[&nbsp;<a href="refs_bib.html#Talattof2016">bib</a>&nbsp;| 
<a href="http://dx.doi.org/10.1021/acs.molpharmaceut.5b00774">DOI</a>&nbsp;| 
<a href="http://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5b00774">http</a>&nbsp;]

</td>
</tr>
</table>

